Cited by 51Viral Infectious Diseases and Gene Expression in InsectsAnimal Genetics and ReproductionVirus-based gene therapy research

Selection of high-producing CHO cells using NPT selection marker with reduced enzyme activity

Sautter, Kerstin, Enenkel, Barbara·2005·Biotechnology and Bioengineering

Abstract

We developed an expression system that aimed to increase the proportion of high producers in a transfected cell population in order to reduce the effort in clone screening. The principle is based on the impairment of the selection marker. Twelve single‐point mutations in more or less conserved domains of the resistance marker gene neomycin‐phosphotransferase (NPT) resulted in different degrees of reduced enzyme activity, depending on the amino acid conservation and the kind of amino acid exchange. In all transfected, mutant‐NPT bearing CHO‐DG44 cell pools surviving the selection with G418, the ratio of high‐producing cells to total cell number was higher than in pools selected with wildtype‐NPT. Furthermore, these pools showed, in comparison to wildtype‐NPT selected pools, not only higher NPT‐RNA levels but also increased specific productivities and higher titers of a coexpressed biopharmaceutically relevant product. Elevated productivity could be ascribed to higher gene copy numbers, integration into chromatin regions with higher transcriptional activity, or a combination of both effects. Thus, the use of NPT‐mutants as selection markers is suitable for the enrichment of high producers in a transfected CHO‐DG44 cell population, since cell survival is achieved only if the enzymatic impairment of the cointegrated resistance marker is compensated by a higher expression level. © 2005 Wiley Periodicals, Inc.

Integrity signals

Registry

Crossref · 10.1002/bit.20374

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • STAR elements were discovered by a genomic screen of elements that would increase transgene expression.

    “They were discovered by a genomic screen of elements that would increase transgene expression.(Kwaks et al., 2003;Sautter and Enenkel, 2005;Hoeksema et al., 2011;Van Blokland et al., 2011;Harraghy et al., 2015).”

    From Therapeutic glycoprotein production in mammalian cells (2017) · cites this paper as Sautter and Enenkel, 2005

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sautter, K., & Enenkel, B.
Affiliations
Boehringer Ingelheim (Germany) (DE)
Corresponding author
Enenkel, Barbara
Venue
Biotechnology and Bioengineering
Publisher
Wiley
Published
2005-01-24
Volume
89
Issue
5
Pages
530-538
ISSN
  • 0006-3592 (ISSN-L)
  • 1097-0290
OpenAlex
W2029545026
Cited by
51
References
14
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 2 · 2020: 4 · 2019: 1 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 2 · 2013: 5 · 2012: 2
FWCI
0.87
Type
journal article
Language
en
Open access
closed
Locations
  • Biotechnology and Bioengineering (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
neomycin phosphotransferase, reduced enzyme activity, G418 selection, CHO DG44 cells, clone screening, recombinant protein expression, gene copy number, transcriptional activity, point mutations, biopharmaceutical products
MeSH terms
Amino Acid Sequence, Animals, Antibodies, Monoclonal, Cell Survival, Clone Cells, Cricetulus, Genetic Markers, Gentamicins, Cricetinae, Molecular Sequence Data, Recombinant Proteins, Selection, Genetic, Transfection, Gene Expression, CHO Cells, Point Mutation, Protein Structure, Tertiary, Chemokine CCL2, Kanamycin Kinase, Amino Acid Motifs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review